BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10652300)

  • 1. Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2.
    Yam CH; Siu WY; Lau A; Poon RY
    J Biol Chem; 2000 Feb; 275(5):3158-67. PubMed ID: 10652300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2.
    Yam CH; Ng RW; Siu WY; Lau AW; Poon RY
    Mol Cell Biol; 1999 Jan; 19(1):635-45. PubMed ID: 9858587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
    Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
    Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2.
    Desai D; Wessling HC; Fisher RP; Morgan DO
    Mol Cell Biol; 1995 Jan; 15(1):345-50. PubMed ID: 7799941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell cycle inhibitor p21CIP is phosphorylated by cyclin A-CDK2 complexes.
    Jaumot M; Estañol JM; Casanovas O; Graña X; Agell N; Bachs O
    Biochem Biophys Res Commun; 1997 Dec; 241(2):434-8. PubMed ID: 9425288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of changing the site of activating phosphorylation in CDK2 from threonine to serine.
    Kaldis P; Cheng A; Solomon MJ
    J Biol Chem; 2000 Oct; 275(42):32578-84. PubMed ID: 10931829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-stimulated binding of Cks proteins to cyclin-dependent kinases.
    Egan EA; Solomon MJ
    Mol Cell Biol; 1998 Jul; 18(7):3659-67. PubMed ID: 9632748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma.
    Li KK; Ng IO; Fan ST; Albrecht JH; Yamashita K; Poon RY
    Liver; 2002 Jun; 22(3):259-68. PubMed ID: 12100577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression.
    Sørensen CS; Lukas C; Kramer ER; Peters JM; Bartek J; Lukas J
    Mol Cell Biol; 2001 Jun; 21(11):3692-703. PubMed ID: 11340163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
    Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
    Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
    Blain SW; Montalvo E; Massagué J
    J Biol Chem; 1997 Oct; 272(41):25863-72. PubMed ID: 9325318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the in vitro reconstituted cyclin A or B1-dependent cdk2 and cdc2 kinase activities.
    Pan ZQ; Amin A; Hurwitz J
    J Biol Chem; 1993 Sep; 268(27):20443-51. PubMed ID: 8397207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
    Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
    Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells.
    Arooz T; Yam CH; Siu WY; Lau A; Li KK; Poon RY
    Biochemistry; 2000 Aug; 39(31):9494-501. PubMed ID: 10924145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin E-CDK2 is a regulator of p27Kip1.
    Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
    Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro.
    Connell-Crowley L; Solomon MJ; Wei N; Harper JW
    Mol Biol Cell; 1993 Jan; 4(1):79-92. PubMed ID: 8443411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells.
    Jin YH; Yoo KJ; Lee YH; Lee SK
    J Biol Chem; 2000 Sep; 275(39):30256-63. PubMed ID: 10884382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.